Hot Biotech Gainers: Sangamo Biosciences (NASDAQ:SGMO), CEL-SCI Corporation (NYSEMKT:CVM), Agios Pharmaceuticals (NASDAQ:AGIO), Lpath (NASDAQ:LPTN)
HIV usually infects blood cells through a protein on their surface, a “docking station” called CCR5. A California company, Sangamo BioSciences Inc. (NASDAQ:SGMO), makes a treatment that can knock out a gene that makes CCR5. Sangamo Biosciences, Inc. (NASDAQ:SGMO) stock performance was 17.08% in last session and finished the day at $22.96. Traded volume was 11.36 million shares in the last session and the average … Continue reading Hot Biotech Gainers: Sangamo Biosciences (NASDAQ:SGMO), CEL-SCI Corporation (NYSEMKT:CVM), Agios Pharmaceuticals (NASDAQ:AGIO), Lpath (NASDAQ:LPTN)
Stock in Action: Google (NASDAQ GOOG) Set To Enter the Mobile Payment Market
Google (NASDAQ GOOG) are set to enter the mobile payment market. They would come in direct competition with Apple. Google (NASDAQ GOOG) are planning to launch their own version of Google Wallet which would be a major competitor to the other mobile payment companies. Some of the other major companies in this segment include the likes of Samsung and Apple. It would be interesting to … Continue reading Stock in Action: Google (NASDAQ GOOG) Set To Enter the Mobile Payment Market
Gilead (NASDAQ:GILD) Altripla Recall a Non-Issue According to Deutsche Bank
Deutsche Bank said Gilead(NASDAQ:GILD)’s Atripla recall is not an issue. The firm said Gilead proactively issued the recall following a typical quality check that found small particles and notes the company has multiple manufacturers for Atripla. Management said it was a minor issue and that Atripla supply is more than enough. Shares are Buy rated with a $132 price target. In a note issued by … Continue reading Gilead (NASDAQ:GILD) Altripla Recall a Non-Issue According to Deutsche Bank
Copa Holdings S.A. Cl A (NYSE:CPA) Downgraded by Citi
Copa Holdings S.A. Cl A (NYSE:CPA) trades down 9% Thursday after Citi downgraded the Panama-based cargo and passenger airline to Neutral from Buy. Citi analysts cut their price target on shares of Copa (NYSE:CPA) to $148 from $170. Below are the highlights outlined by the analyst at Citi: Venezuela’s decision to sever diplomatic and commercial ties with Panama is part of a stunning turn of … Continue reading Copa Holdings S.A. Cl A (NYSE:CPA) Downgraded by Citi
Facebook (NASDAQ:FB) Finds Resistance; Twitter (NYSE:TWTR) Trading Higher
Facebook (NASDAQ: FB) shares are trading lower by $0.43 at $71.14 in Thursday’s trading. For the second day in a row, the contract has found resistance just under $72.00. After reaching $71.97 on Wednesday, FB stopped just shy of that level at $71.89 before retreating to $70.98. Facebook (NASDAQ:FB)’s stock on March 6, 2014 was down .73% trading at $71.04 mid afternoon. Its fifty two week … Continue reading Facebook (NASDAQ:FB) Finds Resistance; Twitter (NYSE:TWTR) Trading Higher
Tech Sector Updates: Sodastream (NASDAQ:SODA) Advances, Pixelworks (NASDAQ:PXLW), Apple (NASDAQ:AAPL)
SodaStream (NASDAQ:SODA) advances after Tilson touts shares Shares of SodaStream (NASDAQ:SODA), which makes at-home soda makers, are climbing after well-known hedge fund manager Whitney Tilson revealed that he had established a position in the stock and wrote an upbeat article about the company. Tilson wrote in the article dated yesterday that after conducting a survey he does not believe that SodaStream (NASDAQ:SODA)’s product is a fad, … Continue reading Tech Sector Updates: Sodastream (NASDAQ:SODA) Advances, Pixelworks (NASDAQ:PXLW), Apple (NASDAQ:AAPL)